Cover Image
市場調查報告書

Nuo Therapeutics, Inc.的產品平台分析

Nuo Therapeutics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 336713
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
Nuo Therapeutics, Inc.的產品平台分析 Nuo Therapeutics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年06月30日 內容資訊: 英文 34 Pages
簡介

本報告提供Nuo Therapeutics, Inc.的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台分析與最新趨勢,現在暫停中的計劃等資訊。

Nuo Therapeutics, Inc.的基本資料

Nuo Therapeutics, Inc.概要

  • 主要資訊
  • 企業資料

Nuo Therapeutics, Inc.:R&D概要

  • 主要的治療範圍

Nuo Therapeutics, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Nuo Therapeutics, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Nuo Therapeutics, Inc.:藥物簡介

  • ALD-301
  • ALD-201
  • ALD-451
  • ALD-601
  • CT-112

Nuo Therapeutics, Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Nuo Therapeutics, Inc.:最近的開發平台趨勢

Nuo Therapeutics, Inc.:暫停中的計劃

Nuo Therapeutics, Inc.:企業發表

Nuo Therapeutics, Inc.:總公司和子公司的所在地

附錄

目錄
Product Code: GMDHC07217CDB

Summary

Global Markets Direct's, 'Nuo Therapeutics, Inc. - Product Pipeline Review - 2015', provides an overview of the Nuo Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nuo Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Nuo Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nuo Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nuo Therapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Nuo Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nuo Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nuo Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nuo Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nuo Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Nuo Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Nuo Therapeutics, Inc. Snapshot
    • Nuo Therapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Nuo Therapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Nuo Therapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Nuo Therapeutics, Inc. - Pipeline Products Glance
    • Nuo Therapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Nuo Therapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Nuo Therapeutics, Inc. - Drug Profiles
    • ALD-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALD-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALD-451
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALD-601
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CT-112
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Nuo Therapeutics, Inc. - Pipeline Analysis
    • Nuo Therapeutics, Inc. - Pipeline Products by Route of Administration
    • Nuo Therapeutics, Inc. - Pipeline Products by Molecule Type
  • Nuo Therapeutics, Inc. - Recent Pipeline Updates
  • Nuo Therapeutics, Inc. - Dormant Projects
  • Nuo Therapeutics, Inc. - Company Statement
  • Nuo Therapeutics, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Nuo Therapeutics, Inc., Key Information
  • Nuo Therapeutics, Inc., Key Facts
  • Nuo Therapeutics, Inc. - Pipeline by Indication, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Nuo Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Nuo Therapeutics, Inc. - Phase II, 2015
  • Nuo Therapeutics, Inc. - Phase I, 2015
  • Nuo Therapeutics, Inc. - Preclinical, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Route of Administration, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Molecule Type, 2015
  • Nuo Therapeutics, Inc. - Recent Pipeline Updates, 2015
  • Nuo Therapeutics, Inc. - Dormant Developmental Projects,2015
  • Nuo Therapeutics, Inc., Subsidiaries

List of Figures

  • Nuo Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Stage of Development, 2015
  • Nuo Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Nuo Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top